-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603.O2.6 603. Oncogenes and Tumor Suppressors: Transcriptional Control and Dysregulation in Hematopoiesis and Leukemia

Oncogenes and Tumor Suppressors Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 10:30 AM-12:00 PM
W308, Level 3 (Orange County Convention Center)
Moderators:
Ann-Kathrin Eisfeld, MD, The Ohio State University Comprehensive Cancer Center and Yong-Mi Kim, MD PhD MPH, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California

Disclosures:
No relevant conflicts of interest to declare.
10:30 AM

Marie-Claude Sincennes1*, Magali Humbert1*, Benoit Grondin1*, Christophe Cazaux2*, Veronique Lisi1*, Nazar Mashtalir3*, EL Bachir Affar3*, Alain Verreault1* and Trang Hoang1

1Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada
2Cancer Research Center of Toulouse, Toulouse, France
3Department of Medicine, Maisonneuve-Rosemont Hospital Research Center, Montreal, QC, Canada

10:45 AM

Konstantinos Tzelepis, MSc1*, Hiroko Koike-Yusa, MD1*, Etienne De Braekeleer, PhD1*, Yilong Li1*, Emmanouil Metzakopian, PhD1*, Oliver M. Dovey, PhD1*, Annalisa Mupo, PhD1*, Vera Grinkevich, PhD1*, Milena M. Mazan, PhD1*, Malgorzata Gozdecka, PhD1*, Jonathan L. Cooper1*, Miten Patel, MD1*, Thomas David Hardman McKerrell, MD1*, Bin Chen1*, Hannes Ponstingl, PhD1*, Brian J.P Huntly, MD, PhD2*, Ultan McDermott, MD, PhD1*, Julio Saez-Rodriguez, PhD3*, Francesco Iorio, PhD3*, Kosuke Yusa, PhD1* and George S. Vassiliou, MD, PhD1*

1Wellcome Trust Sanger Institute, Cambridge, United Kingdom
2Cambridge Institute for Medical Research, Cambridge, United Kingdom
3EMBL European Bioinformatics Institute, Cambridge, United Kingdom

11:00 AM

Yunzhu Dong1,2*, Yoshihiro Hayashi, MD, PhD1, Xiaomei Yan, MD, PhD1*, Feng Xue, PhD1*, Wei Chen, PhD2* and Gang Huang, PhD1

1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
2Beijing Institute of Biotechnology, Beijing, China

11:15 AM

Qiang Li, PhD1*, Christian Hurtz, PhD1*, Seyedmehdi Shojaee, PhD1*, Zhengshan Chen, MD PhD1*, Huimin Geng, PhD1*, Gang Xiao, PhD1*, Mignon L. Loh, MD2, B. Hilda Ye, PhD3, Ari Melnick, MD4 and Markus Muschen, MD PhD1

1Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
2Department of Pediatrics, Benioff Children’s Hospital, University of California San Francisco, San Francisco, CA
3Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
4Department of Medicine, Weill Cornell Medical College, New York, NY

11:30 AM

Therese Vu, BSc1*, Claudia Bruedigam1*, Axia Song1*, Solene Guignes1*, Rebecca Austin1*, Sebastien Jacquelin1*, Alistair Chalk2*, Carl Walkley, PhD, BPharm2, Claudia Scholl3, Stefan Fröhling, MD3 and Steven W. Lane, MD1

1QIMR Berghofer Medical Research Institute, Brisbane, Australia
2Stem Cell Regulation Unit, St. Vincent's Institute, Melbourne, Australia
3National Center for Tumor Diseases, Heidelberg, Germany

11:45 AM

Jane Healy, MD, PhD1, Rachel E Rempel, PhD2*, Andrea B. Moffitt2*, Nicholas Davis2*, Jenny Zhang2*, Cassandra Love2*, Jennifer R Shingleton, PhD2* and Sandeep Dave, MD3

1Department of Medicine, Division of Hematologic Malignancies, Duke University Medical Center, Durham, NC
2Duke University, Durham, NC
3Duke University Medical Center, Durham, NC

*signifies non-member of ASH